These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6150556)

  • 1. Glucuronide conjugation reduces the cytotoxicity but not the mutagenicity of benzo(a)pyrene in the CHO/HGPRT assay.
    Recio L; Hsie AW
    Teratog Carcinog Mutagen; 1984; 4(5):391-402. PubMed ID: 6150556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulative effects of metabolic effectors on benzo(a)pyrene-induced cytotoxicity and mutagenicity in mammalian cells.
    Hsie AW; Recio L
    Toxicol Ind Health; 1994; 10(3):181-9. PubMed ID: 7855867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the cytotoxicity and mutagenicity of benzo[a]pyrene and benzo[a]pyrene 7,8-diol by glutathione and glutathione S-transferases in mammalian cells (CHO/HGPRT assay).
    Recio L; Hsie AW
    Mutat Res; 1987 Jun; 178(2):257-69. PubMed ID: 3587256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of cytotoxicity and mutagenicity of benzo[a]pyrene in mammalian cells (CHO/HGPRT system).
    Machanoff R; O'Neill JP; Hsie AW
    Chem Biol Interact; 1981 Feb; 34(1):1-10. PubMed ID: 7460073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and mutagenicity of coal oils in the CHO/HGPRT assay.
    DeMarini DM; Brimer PA; Hsie AW
    Environ Mutagen; 1984; 6(4):517-27. PubMed ID: 6468346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of benzo(a)pyrene metabolism with microsomes by addition of uridine 5'-diphosphoglucuronic acid.
    Nemoto N; Takayama S
    Cancer Res; 1977 Nov; 37(11):4125-9. PubMed ID: 908046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between benzo(a)pyrene diol-epoxide-DNA adducts and mutagenicity in the CHO/HPGRT assay.
    Recio L; Shugart LR; Hsie AW
    Fundam Appl Toxicol; 1987 Feb; 8(2):243-52. PubMed ID: 3104121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
    Zhong Z; Kauffman FC; Thurman RG
    Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of hGSTM1-1 against B[a]P and (+)- or (-)-B[a]P-7,8-dihydrodiol cytotoxicity, mutagenicity, and macromolecular adducts in V79 cells coexpressing hCYP1A1.
    Kushman ME; Kabler SL; Ahmad S; Doehmer J; Morrow CS; Townsend AJ
    Toxicol Sci; 2007 Sep; 99(1):51-7. PubMed ID: 17525473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metabolic activation on the cytotoxicity and mutagenicity of 1,2-dibromoethane in the CHO/HGPRT system.
    Brimer PA; Tan EL; Hsie AW
    Mutat Res; 1982 Aug; 95(2-3):377-88. PubMed ID: 6750385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems.
    Teel RW
    Cancer Lett; 1984 Oct; 24(3):281-9. PubMed ID: 6388822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of superoxide generated in vitro on glucuronidation of benzo[a]pyrene metabolites by mouse liver microsomes.
    Byczkowski JZ; Gessner T
    Int J Biochem; 1987; 19(6):531-7. PubMed ID: 3038635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.
    Rubano DC; Teel RW; Strother A
    Cancer Lett; 1990 Jul; 52(2):123-31. PubMed ID: 2116220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of benzo[a]pyrene and (-)-trans-benzo[a]pyrene-7,8-dihydrodiol by freshly isolated hepatocytes from mirror carp.
    Zaleski J; Steward AR; Sikka HC
    Carcinogenesis; 1991 Feb; 12(2):167-74. PubMed ID: 1995182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo[a]pyrene-3,6-quinone- versus Benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells.
    Grove AD; Llewellyn GC; Kessler FK; White KL; Crespi CL; Ritter JK
    Toxicol Appl Pharmacol; 2000 Jan; 162(1):34-43. PubMed ID: 10631125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.